Fate Therapeutics, Inc. (FATE)
1.46
+0.06
(+4.29%)
USD |
NASDAQ |
Feb 20, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
Fate Therapeutics EPS Diluted (TTM) : -1.319 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| MannKind Corp. | 0.0942 |
| Vertex Pharmaceuticals, Inc. | 15.33 |
| Ardelyx, Inc. | -0.2576 |
| ACADIA Pharmaceuticals, Inc. | 1.554 |
| Alnylam Pharmaceuticals, Inc. | 2.257 |